We are live on ! Find out more
LLY icon

Eli Lilly

3,897 hedge funds and large institutions have $583B invested in Eli Lilly in 2025 Q3 according to their latest regulatory filings, with 215 funds opening new positions, 1,792 increasing their positions, 1,456 reducing their positions, and 163 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 215 | Existing positions closed: 163

23% more repeat investments, than reductions

Existing positions increased: 1,792 | Existing positions reduced: 1,456

0% less funds holding

Funds holding: 3,9063,897 (-9)

4% less capital invested

Capital invested by funds: $610B → $583B (-$26.6B)

8% less call options, than puts

Call options by funds: $12.7B | Put options by funds: $13.9B

1.82% less ownership

Funds ownership: 82.66%80.84% (-1.8%)

13% less funds holding in top 10

Funds holding in top 10: 291254 (-37)

Holders
3,897
Holders Change
-9
Holders Change %
-0.23%
% of All Funds
51.14%
Holding in Top 10
254
Holding in Top 10 Change
-37
Holding in Top 10 Change %
-12.71%
% of All Funds
3.33%
New
215
Increased
1,792
Reduced
1,456
Closed
163
Calls
$12.7B
Puts
$13.9B
Net Calls
-$1.15B
Net Calls Change
-$4.56B
Name Holding Trade Value Shares
Change
Change in
Stake
Franklin Resources
26
Franklin Resources
California
$3.69B +$54.6M +73,323 +2%
AllianceBernstein
27
AllianceBernstein
Tennessee
$3.67B -$301M -403,871 -8%
Janus Henderson Group
28
Janus Henderson Group
United Kingdom
$3.45B +$106M +143,012 +3%
Fisher Asset Management
29
Fisher Asset Management
Washington
$3.4B +$112M +150,595 +4%
Jennison Associates
30
Jennison Associates
New York
$3.2B -$931M -1,251,164 -23%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$3.09B +$165M +222,125 +6%
UBS Group
32
UBS Group
Switzerland
$3.03B +$37.8M +50,838 +1%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$2.87B +$54.8M +73,658 +2%
Deutsche Bank
34
Deutsche Bank
Germany
$2.5B -$167M -224,313 -6%
Wells Fargo
35
Wells Fargo
California
$2.46B +$77.5M +104,108 +3%
Invesco
36
Invesco
Georgia
$2.32B -$142M -191,138 -6%
Ameriprise
37
Ameriprise
Minnesota
$2.27B +$38.8M +52,090 +2%
Swiss National Bank
38
Swiss National Bank
Switzerland
$1.77B -$87.1M -117,000 -5%
Edgewood Management
39
Edgewood Management
Connecticut
$1.66B +$146M +196,611 +10%
Victory Capital Management
40
Victory Capital Management
Texas
$1.55B +$554M +744,868 +48%
American Century Companies
41
American Century Companies
Missouri
$1.5B +$90M +120,905 +7%
Sumitomo Mitsui Trust Group
42
Sumitomo Mitsui Trust Group
Japan
$1.49B +$19.3M +25,931 +1%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.47B -$62M -83,310 -4%
HSBC Holdings
44
HSBC Holdings
United Kingdom
$1.43B -$78.8M -105,881 -5%
Schroder Investment Management Group
45
Schroder Investment Management Group
United Kingdom
$1.42B -$35.7M -47,982 -3%
Neuberger Berman Group
46
Neuberger Berman Group
New York
$1.33B +$143M +192,240 +12%
Mitsubishi UFJ Asset Management
47
Mitsubishi UFJ Asset Management
Japan
$1.26B +$58M +77,931 +5%
Polen Capital Management
48
Polen Capital Management
Florida
$1.24B -$85.5M -114,943 -7%
National Pension Service
49
National Pension Service
South Korea
$1.21B +$36.5M +48,994 +3%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.2B +$19.9M +26,701 +2%

LLY Hedge Fund Activity: Q3 2025 in Review

3,897 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q3 2025, worth a combined $583B — down 4.4% from $610B a quarter earlier.

Buyers outnumbered sellers: 215 funds opened new LLY positions and 163 closed out — a net gain of 52 holders — while 1,792 added to existing stakes and 1,456 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $3.22B. The largest seller was T. Rowe Price Associates, cutting an estimated $2.51B.

  • 3,897 institutional investors held Eli Lilly (LLY) as of Q3 2025, down from 3,906 in Q2 2025.
  • Funds reported $583B of Eli Lilly stock for Q3 2025, down 4.4% quarter-over-quarter.
  • 215 funds opened new Eli Lilly positions in Q3 2025 and 163 closed out, a net change of +52 holders.
  • The largest Eli Lilly buyer in Q3 2025 was Capital Research Global Investors, an estimated $3.22B added.
  • The largest Eli Lilly seller in Q3 2025 was T. Rowe Price Associates, an estimated $2.51B sold.

Based on aggregated 13F filings for Q3 2025.